Healthcare

Aurobindo Pharma Limited (AUROPHARMA) Q3 FY22 Earnings Concall Transcript

● Feb 10, 2022

Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra — Investor Relations Department...

IPO Alert: Rainbow Children’s Medicare Limited files for initial public offering

● Feb 3, 2022

The estimated size of the hospital market in India was ₹4,270 billion in the fiscal year 2020, representing an annual...

Jubilant Ingrevia Ltd Q3 FY22 Earnings Conference Call Insights

● Feb 2, 2022

Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY22 Earnings Concall Management Update: JUBLINGREA commented that with its capex plans...

Marico Ltd (MARICO) Q3 FY22 Earnings Concall Transcript

● Jan 28, 2022

Marico Ltd (NSE:MARICO) Q3 FY22 Earnings Concall dated Jan. 28, 2022 Corporate Participants: Saugata Gupta — Managing Director & Chief Executive...

Cipla Limited (CIPLA) Q2 FY22 Research Summary

● Jan 28, 2022

The pharma giant Cipla’s net profit rose 7.57% year-on-year (YoY) to Rs 712 crore for Q2 FY22. Cipla market research...

SBI LIFE INSURANCE CO LTD (SBILIFE) Q3 FY22 Earnings Concall Transcript

● Jan 21, 2022

SBI LIFE INSURANCE CO LTD (NSE:SBILIFE) Q3 FY22 Earnings Concall dated Jan. 21, 2022 Corporate Participants: Mahesh Kumar Sharma — Managing...

IPO Alert: API Holdings files DRHP with SEBI for public issue

● Nov 19, 2021

Healthcare spending in India grew at a healthy compound annual rate of 13% from 2015 to 2019 and reached around...

IPO Alert: Wellness Forever Medicare files papers for a public listing

● Oct 20, 2021

The Indian pharmaceutical industry is the world’s third-largest by volume and 14th largest by value. The turnover of the country’s...

IPO Alert: Medanta hospital chain files papers for public listing

● Oct 19, 2021

The hospital industry in India is forecasted to grow to ₹8.6 trillion by 2022 from ₹4 trillion in 2017, at...

IPO Alert: Sahajanand Medical Technologies is all set to go public

● Oct 15, 2021

The global peripheral intervention market is projected to grow from $3.26 billion in 2020 to $5.89 billion in 2026, at...